• STAT+: Pharmalittle: U.S. government blunder contributed to monkeypox vax shortage; Amgen to pay $4 billion for ChemoCentryx

    13 days ago - By STAT

    Top of the morning to you. Another steamy day is unfolding here at the Pharmalot campus, where the short person will soon leave for a day of summertime fun. As for the rest of us, well, we can only dream. But our to-do list will keep us busy, including online meetings with some interesting folks. Hopefully, you can relate. Either way, it is time to get cracking and fire up the coffee kettle. Our choice today is vanilla macadamia nut. As always, we have also gathered a few tidbits to get you going. Have a grand day and keep us in mind if you hear anything provocative or revolutionary...
    The...
    Read more ...

     

  • STAT+: Amgen to acquire ChemoCentryx for $4 billion, adding newly approved drug for autoimmune disorder

    13 days ago - By STAT

    Amgen said Thursday that it will acquire the small drugmaker ChemoCentryx for $4 billion to obtain a newly approved medicine that treats patients with a serious autoimmune condition.
    ChemoCentryx is being purchased for $52 per share, or a 116% premium to its Wednesday closing price. Continue to STAT+ to read the full story...
    Read more ...